6-33194833-G-GGGTGGA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_021976.5(RXRB):c.1455-5_1455-4insTCCACC variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 1,612,780 control chromosomes in the GnomAD database, including 230 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0029 ( 24 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 206 hom. )
Consequence
RXRB
NM_021976.5 splice_region, splice_polypyrimidine_tract, intron
NM_021976.5 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.10
Genes affected
RXRB (HGNC:10478): (retinoid X receptor beta) This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). The encoded protein forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. This gene lies within the major histocompatibility complex (MHC) class II region on chromosome 6. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 6-33194833-G-GGGTGGA is Benign according to our data. Variant chr6-33194833-G-GGGTGGA is described in ClinVar as [Benign]. Clinvar id is 779906.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00294 (448/152326) while in subpopulation EAS AF= 0.0519 (269/5184). AF 95% confidence interval is 0.0468. There are 24 homozygotes in gnomad4. There are 251 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 448 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXRB | NM_021976.5 | c.1455-5_1455-4insTCCACC | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000374680.4 | NP_068811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXRB | ENST00000374680.4 | c.1455-5_1455-4insTCCACC | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_021976.5 | ENSP00000363812 | P4 | |||
RXRB | ENST00000374685.8 | c.1467-5_1467-4insTCCACC | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000363817 | A1 | ||||
RXRB | ENST00000483281.5 | c.*967-5_*967-4insTCCACC | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant | 5 | ENSP00000431369 | |||||
RXRB | ENST00000483821.1 | n.417-5_417-4insTCCACC | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00297 AC: 452AN: 152208Hom.: 25 Cov.: 32
GnomAD3 genomes
AF:
AC:
452
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00521 AC: 1283AN: 246186Hom.: 39 AF XY: 0.00517 AC XY: 694AN XY: 134206
GnomAD3 exomes
AF:
AC:
1283
AN:
246186
Hom.:
AF XY:
AC XY:
694
AN XY:
134206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00192 AC: 2801AN: 1460454Hom.: 206 Cov.: 32 AF XY: 0.00199 AC XY: 1446AN XY: 726516
GnomAD4 exome
AF:
AC:
2801
AN:
1460454
Hom.:
Cov.:
32
AF XY:
AC XY:
1446
AN XY:
726516
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00294 AC: 448AN: 152326Hom.: 24 Cov.: 32 AF XY: 0.00337 AC XY: 251AN XY: 74490
GnomAD4 genome
AF:
AC:
448
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
251
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
175
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
RXRB-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at